NAT10 and melanoma: In melanoma, NAT10 installs ac4C on DDX41 and ZNF746 transcripts to drive dacarbazine resistance; NAT10 inhibition (Remodelin) resensitized tumors in mice, nominating ac4C as a tractable axis.